CIAM
ANRO icon

Caitong International Asset Management’s Alto Neuroscience ANRO Stock Holding History

Caitong International Asset Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2
Closed -$4 – 2599
2025
Q2 		$4 Sell
2
-20
-91% -$48 ﹤0.01% 1911
2025
Q1 		$48 Buy
+22
New +$79 ﹤0.01% 2038

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Caitong International Asset Management's ANRO Position: Q3 2025 in Review

Caitong International Asset Management sold out of Alto Neuroscience (ANRO) in Q3 2025, closing a stake of 2 shares — an estimated $4 sold.

Caitong International Asset Management first reported a position in ANRO in Q1 2025 and held it in 2 quarters. The position peaked at $48 in Q1 2025. 77 funds tracked by Wall St. Rank hold ANRO as of Q3 2025.

  • Caitong International Asset Management reported no remaining Alto Neuroscience position as of Q3 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 2 Alto Neuroscience shares in Q3 2025, an estimated $4.
  • Caitong International Asset Management first reported a position in Alto Neuroscience in Q1 2025 and held it in 2 quarters.
  • Caitong International Asset Management's Alto Neuroscience position peaked at $48 in Q1 2025.
  • 77 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2025.

Based on Caitong International Asset Management's 13F filing for Q3 2025, filed 19 Nov 2025.